Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Parallel solution- and solid-phase synthesis of spirohydantoin derivatives as neurokinin-1 receptor ligandsKonrad H Bleicher, Yves Wüthrich, Maxime De Boni, et al.
Journal of Medicinal Chemistry|July 27, 2013
Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffoldDaniel Ramsbeck, Mirko Buchholz, Birgit Koch, et al.
Biological Chemistry|January 31, 2007
Does human attractin have DP4 activity?Daniel Friedrich, Torsten Hoffmann, Joachim Bär, et al.
Biological Chemistry|February 3, 2011
Selective inhibition of dipeptidyl peptidase 4 by targeting a substrate-specific secondary binding siteKerstin Kühn-Wache, Joachim W Bär, Torsten Hoffmann, et al.
Biochimica Et Biophysica Acta|September 29, 2006
Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cellsHolger Cynis, Stephan Schilling, Mandy Bodnár, et al.
Journal of Molecular Biology|December 7, 2005
Rigidity and flexibility of dipeptidyl peptidase IV: crystal structures of and docking experiments with DPIVMichael Engel, Torsten Hoffmann, Susanne Manhart, et al.
Biological Chemistry|November 4, 2008
Isoaspartate residues dramatically influence substrate recognition and turnover by proteasesLivia Böhme, Joachim Wolfgang Bär, Torsten Hoffmann, et al.
Biochemical and Biophysical Research Communications|March 9, 2002
Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1Simon A Hinke, Kerstin Kühn-Wache, Torsten Hoffmann, et al.
Regulatory Peptides|September 16, 2003
Localization, transmission, spontaneous mutations, and variation of function of the Dpp4 (Dipeptidyl-peptidase IV; CD26) gene in ratsTim Karl, Wojciech T Chwalisz, Dirk Wedekind, et al.
Pageof 8